Companies/Resonate Blends, Inc.

Company profile

Resonate Blends, Inc.

OTC: KOAN · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ North Bergen, CACIK 0000897078Reports USD

#798 of 1,394 Healthcare companies by revenuetop-decile growth

EA Score

——

FH —DQ 33GM —SS 46

v0.1 · 25/100 weight · pillars only

↑ revenue growth (YoY), 3-yr revenue growth · ↓ growth stability, filing timeliness

Methodology →

Revenue TTM

$1.5M

Rev growth YoY (TTM)

-32.1%

Net income (FY)

-$2.1M

Employees

Market cap

$156.2k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$1.9M$1.9M2024

Net income-$2.1M-$2.1M2024

Operating income-$1.7M-$1.7M2024

Total assets$1.9M$1.9M2024

Liabilities$3.1M$3.1M2023

Equity-$3.2M-$3.2M2024

Revenue trend

FY2016 – FY2024 · USD

$103.1k

FY16

$943.7k

FY18

$1.1M

FY18

$1.1M

FY19

$27.0k

FY21

$49.5k

FY22

$16.5k

FY23

$1.9M

FY24

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Resonate Blends, Inc. booked $1.9M in FY2024 revenue, growing 11415% year over year — faster than 99% of Healthcare companies we track, at a -112.5% net margin.

Peers · Healthcare

VMS Rehab Systems, Inc.——Petros Pharmaceuticals, Inc.48D BioLife Sciences Inc.——Innovation Pharmaceuticals Inc.——

Key facts

CEOJames W. Zimbler

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersNorth Bergen, CA

ExchangeOTC: KOAN

Employees6

IPO date1993-03-31

Latest filings

10-Q2025-06-16 10-K2025-06-10 8-K2025-03-14 10-Q2024-11-26 10-Q2024-08-21 8-K2024-08-12 10-Q2024-05-20 10-K2024-04-16

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.